Injection/Infusion
EYLEA SOLUTION FOR INTRAVITREAL INJECTION IN PRE-FILLED SYRINGE 40MG/ML
Summary
EYLEA SOLUTION FOR INTRAVITREAL INJECTION IN PRE-FILLED SYRINGE 40MG/ML — Injection/Infusion containing aflibercept. Hong Kong Registration No. HK-67381. Certificate Holder: BAYER HEALTHCARE LIMITED. Date of Registration: 02 Mar, 2022.
Product NameEYLEA SOLUTION FOR INTRAVITREAL INJECTION IN PRE-FILLED SYRINGE 40MG/ML
Registration No.HK-67381
Certificate HolderBAYER HEALTHCARE LIMITED
Holder Address14/F, OXFORD HOUSE, TAIKOO PLACE, 979 KING’S ROAD, QUARRY BAY, HONG KONG
Ingredientsaflibercept
Dosage FormInjection/Infusion
Legal ClassificationPart 1, Schedule 1 & Schedule 3 Poison
Sale RequirementPrescription only Medicines
Date of Registration02 Mar, 2022
ATC codesL01XX44, S01LA05
ATC Classification
ATC level 1
L Antineoplastic and Immunomodulating Agents / S Sensory Organs
All ATC groupsL01, S01
本頁為藥物資料查詢工具，並非藥物廣告、推廣或醫療建議。所有資料取自香港特別行政區衞生署藥物辦公室之公開資料，僅供參考；一切以藥物辦公室官方公布為準。 本頁不提供任何療效、適應症或治療用途之陳述。用藥前請諮詢醫生或註冊藥劑師。 本網站遵守香港法例第 231 章《不良廣告（醫藥）條例》之規管。